Active Ingredient(s):Rivastigmine FDA Approved: * April 21, 2000 Pharm Company: *NOVARTIS Category:Alzheimers / Dementia
Rivastigmine (sold under the trade name Exelon among others) is a cholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.
The drug is eliminated through the urine, and appears to have relatively few drug-drug interactions.
* May have multiple approval dates, manufacturers, or labelers. 5 Discussions